|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 104.96 USD | -0.91% |
|
-1.89% | +32.14% |
| 07-29 | Deutsche Bank Adjusts CVS Health Price Target to $116 From $92 | MT |
| 07-29 | X, World Federation of Advertisers settle litigation over GARM dispute | RE |
| Market Cap | 135B 119B 111B 102B 190B 12,945B 195B 1,314B 514B 6,406B 507B 496B 22,144B | P/E 2026 * |
16.9x | P/E 2027 * | 14.7x |
|---|---|---|---|---|---|
| Enterprise Value | 191B 168B 157B 144B 269B 18,286B 276B 1,857B 726B 9,049B 717B 701B 31,281B | EV / Sales 2026 * |
0.47x | EV / Sales 2027 * | 0.44x |
| Free-Float |
71.2% | Yield 2026 * |
2.51% | Yield 2027 * | 2.59% |
Last Transcript: CVS Health Corporation
| 1 day | -0.84% | ||
| 1 week | -1.89% | ||
| Current month | +1.37% | ||
| 1 month | +1.37% | ||
| 3 months | +25.91% | ||
| 6 months | +40.73% | ||
| Current year | +32.14% |
| 1 week | 103.01 |  | 110 |
| 1 month | 101.78 | | 110.68 |
| Current year | 69.51 | | 110.68 |
| 1 year | 61.19 | | 110.68 |
| 3 years | 43.56 | | 110.68 |
| 5 years | 43.56 | | 111.25 |
| 10 years | 43.56 | | 111.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
J. Joyner
CEO | Chief Executive Officer | 62 | 2024-10-16 |
Brian Newman
DFI | Director of Finance/CFO | 57 | 2025-05-11 |
Ali Keshavarz
PSD | President | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
C. Brown
BRD | Director/Board Member | 74 | 2007-02-28 |
Anne Finucane
BRD | Director/Board Member | 73 | 2011-01-19 |
| Director/Board Member | 71 | 2015-03-04 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 5/14/26 | Free | Director | 1,737 | 0.0001% | ||
| 2/28/26 | Tax | Executive/Senior Manager | 7,886 | 0.0006% | ||
| 2/28/26 | Tax | Chief Executive Officer | 1,944 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.91% | -1.89% | +68.33% | +40.41% | 135B | |
| -2.23% | +5.67% | +12.05% | +45.83% | 88.37B | |
| +0.81% | +4.74% | +5.70% | +57.31% | 28.54B | |
| -0.10% | +2.45% | +38.38% | +72.68% | 25.96B | |
| -1.96% | +26.20% | +56.11% | +236.09% | 22.19B | |
| -0.63% | +10.69% | -9.20% | -19.52% | 22.05B | |
| +0.31% | +2.96% | +66.85% | +136.50% | 15.47B | |
| +1.89% | +2.29% | +5.16% | -4.33% | 14.5B | |
| +1.63% | +3.02% | -1.53% | -6.20% | 13.14B | |
| +1.37% | +4.15% | -11.57% | +85.81% | 11.29B | |
| Average | +0.00% | +7.00% | +23.03% | +64.46% | 37.67B | |
| Weighted average by Cap. | -0.75% | +5.54% | +35.73% | +55.16% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 409B 360B 336B 308B 577B 39,216B 591B 3,982B 1,557B 19,406B 1,537B 1,504B 67,085B | 427B 375B 350B 321B 601B 40,873B 616B 4,150B 1,623B 20,225B 1,602B 1,567B 69,919B |
| Net income | 8.04B 7.07B 6.6B 6.06B 11.34B 771B 11.62B 78.25B 30.6B 381B 30.2B 29.55B 1,318B | 9.35B 8.21B 7.67B 7.04B 13.17B 895B 13.49B 90.9B 35.55B 443B 35.09B 34.33B 1,531B |
| Net Debt | 55.76B 49B 45.74B 41.98B 78.58B 5,341B 80.51B 542B 212B 2,643B 209B 205B 9,137B | 52.15B 45.82B 42.77B 39.25B 73.48B 4,995B 75.29B 507B 198B 2,472B 196B 192B 8,545B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-30 | US$104.89 | -0.97% | 2,140,765 |
| 26-07-29 | US$105.92 | -3.13% | 7,718,243 |
| 26-07-28 | US$109.34 | +2.12% | 6,682,269 |
| 26-07-27 | US$107.07 | -0.62% | 7,857,618 |
| 26-07-24 | US$107.74 | +0.80% | 5,370,540 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CVS Stock
Select your edition
All financial news and data tailored to specific country editions
